E3S Web of Conf.
Volume 215, 2020International Scientific Conference on Biotechnology and Food Technology (BFT-2020)
|Number of page(s)||7|
|Section||Biomedical Technology and Biopharmaceuticals|
|Published online||02 December 2020|
Fibrinolytic properties of basidiomycetes Coprinus lagopides and Funalia trogii
1 Saint-Petersburg State Institute of Technology, 198013, 26, Moskovskii pr., St. Peterburg, Russia
2 Pavlov First Saint Petersburg State Medical University, 197022, 6-8, L’va Tolstogo st., St. Petersburg, Russia
* Corresponding author: firstname.lastname@example.org
Currently, the search continues for fibrinolytic and thrombolytic drugs that quickly dissolve blood clots and do not have side effects. One of the directions of these studies is the production of fibrinolytic enzymes from deep cultures of basidiomycetes. This work examines the fibrinolytic activity of culture liquids obtained from two cultures of saprophytic basidiomycetes: Coprinus lagopides and Funalia trogii in comparison with the commercial thrombolytic drug Actilyse.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.